GO:0035382 sterol transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035382 (sterol transmembrane transport) describes the movement of sterols, such as cholesterol, across cellular membranes.
• Sterol transport is essential for membrane integrity, lipid homeostasis, and cell signaling, and defects are linked to diseases like Niemann-Pick type C and cancer [1,6,8].
• Key proteins include NPC1, NPC2, ABCG1, LYCHOS, and Lamp1, which mediate or regulate sterol flux between organelles and the plasma membrane [1,2,4,7].
• Experimental approaches such as CRISPR knockout, knock-in, and overexpression, combined with imaging and lipidomics, are used to dissect sterol transport mechanisms [3,8].
• Dysregulated sterol transport contributes to neurodegeneration, atherosclerosis, and hepatocellular carcinoma progression [6,8].
• Understanding sterol transmembrane transport provides targets for therapeutic intervention in metabolic and neurodegenerative disorders [1,6].
Description
Sterol transmembrane transport (GO:0035382) is the biological process by which sterol molecules are moved across cellular membranes. Sterols are a class of steroids characterized by one or more hydroxyl groups and a hydrocarbon side-chain, with cholesterol being the most abundant in mammalian cells. This process is fundamental for maintaining membrane fluidity, organizing lipid rafts, and facilitating intracellular signaling. Researchers study sterol transmembrane transport to understand how cells distribute cholesterol and other sterols among organelles, and how disruptions contribute to disease [1,5]. The transport is mediated by a network of proteins, including the Niemann-Pick C1 (NPC1) and NPC2 proteins, which export cholesterol from lysosomes, and ATP-binding cassette transporters like ABCG1, which regulate cellular sterol efflux. Recent studies have identified additional players such as LYCHOS, a hybrid transporter-GPCR that senses cholesterol, and Lamp1, which mediates lipid transport in Drosophila. These findings highlight the complexity and physiological importance of sterol transmembrane transport in health and disease [1,2,4,7].
sterol transmembrane transport At A Glance
| GO ID | GO:0035382 |
|---|---|
| GO term | sterol transmembrane transport |
| Ontology | biological_process |
| Synonym | sterol membrane transport |
| Major function | Transport of sterols across cellular membranes |
| Key transporters | NPC1, NPC2, ABCG1, LYCHOS, Lamp1 |
| Associated diseases | Niemann-Pick type C disease, hepatocellular carcinoma, atherosclerosis |
| Research methods | CRISPR knockout/knock-in, imaging, lipidomics, transport assays |
What Is GO:0035382?
According to the Gene Ontology, GO:0035382 sterol transmembrane transport is defined as the process in which a sterol is transported across a membrane. Sterols are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule. This term encompasses the directed movement of sterol molecules from one side of a membrane to the other, which may occur via vesicular or non-vesicular mechanisms and is often mediated by specific transport proteins.
Why Is sterol transmembrane transport Important in Cell Biology?
Sterol transmembrane transport is critical for cellular lipid homeostasis and membrane function, and its dysregulation is implicated in a range of human diseases. For example, mutations in NPC1 cause Niemann-Pick type C disease, a fatal neurodegenerative disorder characterized by lysosomal cholesterol accumulation [1,8]. Additionally, NPC1 has been shown to control TGFBR1 stability and promote hepatocellular carcinoma progression in a cholesterol transport-independent manner, revealing unexpected roles for sterol transport proteins in cancer. ABCG1-mediated sterol efflux influences atherosclerosis and macrophage function. Thus, understanding the molecular mechanisms of sterol transmembrane transport is essential for developing therapeutic strategies for metabolic, neurodegenerative, and oncological disorders [1,6,7].
• Maintains membrane fluidity and lipid raft integrity.
• Regulates intracellular cholesterol distribution and lysosomal function.
• Controls cellular sterol efflux and reverse cholesterol transport.
• Modulates mTORC1 signaling via lysosomal cholesterol sensing.
• Implicated in Niemann-Pick type C disease and neurodegeneration.
• Promotes hepatocellular carcinoma progression through NPC1.
• Influences lipid nanoparticle-mediated mRNA delivery.
• Provides targets for therapeutic intervention in metabolic diseases.
• Essential for Drosophila development and lipid transport.
• Involved in cholesterol sensing by LYCHOS and GPCR signaling.
What Happens During sterol transmembrane transport?
Lysosomal cholesterol export
In simple terms: Cholesterol is moved out of the lysosome so the cell can use it.
In the lysosome, cholesterol derived from lipoprotein uptake is exported by the concerted action of NPC2 and NPC1. NPC2 binds cholesterol and transfers it to NPC1, which then mediates its transport across the lysosomal membrane. This process is essential for maintaining cellular cholesterol homeostasis, and its failure leads to lysosomal cholesterol accumulation as seen in Niemann-Pick type C disease [1,8].
Plasma membrane sterol efflux
In simple terms: Cells pump excess cholesterol out to prevent buildup.
ABCG1, an ATP-binding cassette transporter, facilitates the efflux of cholesterol and other sterols from cells to extracellular acceptors such as HDL. This transport is critical for reverse cholesterol transport and prevents cholesterol accumulation in macrophages, thereby protecting against atherosclerosis.
Intracellular sterol trafficking
In simple terms: Cholesterol is shuttled between different parts of the cell.
Sterols are transported between the plasma membrane, endoplasmic reticulum, and other organelles via both vesicular and non-vesicular mechanisms. Proteins such as Lamp1 mediate lipid transport in Drosophila, and LYCHOS functions as a cholesterol sensor and transporter in mammalian cells [2,4]. These pathways ensure proper distribution of sterols for membrane synthesis and signaling.
Regulation by mTORC1 signaling
In simple terms: Cholesterol levels tell the cell when to grow.
Lysosomal cholesterol activates mTORC1 through a signaling complex involving SLC38A9 and NPC1. This links sterol transport to nutrient sensing and cell growth control, highlighting the integration of lipid transport with metabolic signaling.
Sterol transport in disease
In simple terms: When cholesterol transport goes wrong, it can cause disease.
Defects in sterol transmembrane transport are associated with Niemann-Pick type C disease, where mutations in NPC1 lead to neurodegeneration. Additionally, NPC1 promotes hepatocellular carcinoma progression by stabilizing TGFBR1 independently of cholesterol transport. These examples underscore the pathological importance of sterol transport [6,8].
Key Genes Involved in GO:0035382 sterol transmembrane transport
The following genes encode proteins that mediate or regulate sterol transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPC1 | Lysosomal cholesterol export | Mutations cause Niemann-Pick type C; linked to HCC [1,6,8] |
| NPC2 | Cholesterol transfer to NPC1 | Defects cause Niemann-Pick type C |
| ABCG1 | Cellular sterol efflux | Implicated in atherosclerosis and lipid metabolism |
| LYCHOS | Cholesterol sensor and transporter | Hybrid PIN transporter-GPCR; regulates mTORC1 |
| Lamp1 | Lipid transport in Drosophila | Mediates lipid transport but dispensable for autophagy |
| SLC38A9 | Lysosomal arginine sensor | Part of mTORC1 activation complex with NPC1 |
| TGFBR1 | TGF-beta receptor | Stabilized by NPC1; promotes HCC |
| mTORC1 | Nutrient sensing kinase | Activated by lysosomal cholesterol |
| ABCA1 | Cholesterol efflux | Similar to ABCG1; not directly cited but related |
| SR-BI | HDL receptor | Mediates selective cholesterol uptake |
| LDLR | LDL uptake | Delivers cholesterol to lysosomes |
| HMGCR | Cholesterol synthesis | Regulated by sterol levels |
| ACAT1 | Cholesterol esterification | Controls free cholesterol |
| Caveolin-1 | Membrane transport | Involved in cholesterol trafficking |
| Annexin A2 | Membrane repair | May facilitate sterol transport |
| ORP1L | Oxysterol transport | Non-vesicular sterol transfer |
| CERT | Ceramide transport | Related lipid transfer |
How Is sterol transmembrane transport Regulated?
Sterol transmembrane transport is regulated at multiple levels. The mTORC1 pathway senses lysosomal cholesterol via a complex containing SLC38A9 and NPC1, thereby coordinating cell growth with sterol availability. Additionally, the expression and activity of transporters like ABCG1 are controlled by nuclear receptors such as LXR in response to cellular cholesterol levels. In Drosophila, Lamp1 mediates lipid transport, but its loss does not impair autophagy, suggesting specialized regulatory roles. These regulatory mechanisms ensure that sterol distribution adapts to metabolic demands [1,2,7].
sterol transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C disease | NPC1 knockout iPSC-derived neurons |
| NPC1 | Hepatocellular carcinoma | NPC1 knockout HCC cell lines |
| ABCG1 | Atherosclerosis | ABCG1 knockout mice |
| NPC2 | Niemann-Pick type C disease | NPC2 mutant fibroblasts |
| LYCHOS | mTORC1 signaling | LYCHOS knockout HEK293T cells |
Niemann-Pick type C disease
Niemann-Pick type C (NPC) is a lysosomal storage disorder caused by mutations in NPC1 or NPC2, leading to impaired lysosomal cholesterol export and accumulation [1,8]. This results in progressive neurodegeneration, hepatosplenomegaly, and early death. Studies using mutant induced neurons and humanized mice have identified proteostatic therapies for NPC.
Hepatocellular carcinoma
NPC1 has been shown to promote hepatocellular carcinoma (HCC) progression by stabilizing TGFBR1 in a cholesterol transport-independent manner. This suggests that NPC1 may serve as a therapeutic target in HCC, beyond its canonical role in sterol transport.
Atherosclerosis
ABCG1-mediated sterol efflux is critical for reverse cholesterol transport and protects against atherosclerosis. Dysregulation of this process leads to cholesterol accumulation in macrophages and plaque formation.
Neurodegeneration
Defects in sterol transmembrane transport contribute to neurodegenerative diseases such as NPC, where cholesterol accumulation in neurons leads to cell death. Understanding these mechanisms may reveal new therapeutic avenues.
From sterol transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NPC1 loss affect lysosomal cholesterol export? | NPC1 knockout HeLa cells |
| Can mutant NPC1 be rescued by proteostatic therapies? | Humanized NPC1 mice |
| What is the role of ABCG1 in macrophage cholesterol efflux? | ABCG1 knockout macrophages |
| How does LYCHOS sense cholesterol? | LYCHOS knockout HEK293T cells |
| Does Lamp1 mediate lipid transport in vivo? | Lamp1 mutant Drosophila |
| Can CRISPR knock-in of tagged NPC1 track transport? | NPC1-GFP knock-in cells |
How to Study the sterol transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Filipin staining | Free cholesterol distribution | Visualizing lysosomal cholesterol accumulation |
| BODIPY-cholesterol | Cholesterol transport dynamics | Live-cell imaging of sterol trafficking |
| CRISPR knockout screens | Gene essentiality for sterol transport | Identifying novel regulators |
| Lipidomics (LC-MS) | Sterol species quantification | Measuring cholesterol and oxysterols |
| Transport assays | Sterol transfer rates | In vitro reconstitution with purified proteins |
| RNA-seq | Transcriptional changes | Assessing sterol-responsive gene expression |
| Proteomics | Protein interactions | Identifying NPC1-containing complexes |
Imaging sterol transport
Fluorescent cholesterol analogs such as filipin and BODIPY-cholesterol are used to visualize sterol distribution and transport in live cells. These methods allow real-time tracking of cholesterol movement between organelles.
Biochemical transport assays
In vitro assays using isolated membranes or liposomes can measure sterol transfer rates mediated by purified proteins like NPC2 and NPC1. Such assays help dissect the molecular mechanisms of transport.
Genetic screens and CRISPR
CRISPR knockout screens have identified genes required for sterol transport, such as NPC1 and ABCG1 [6,7]. These screens enable unbiased discovery of novel regulators.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies sterol species in cells and tissues, revealing changes in cholesterol and oxysterol levels upon genetic manipulation.
How CRISPR Can Be Used to Study GO:0035382 sterol transmembrane transport
Knockout
CRISPR knockout of NPC1 or ABCG1 in cell lines such as HeLa or macrophages abolishes sterol transport, leading to cholesterol accumulation [1,7]. These models are used to study the consequences of transport loss and to test rescue strategies.
Point Mutation
Introducing disease-associated point mutations in NPC1 (e.g., I1061T) via CRISPR allows researchers to study the molecular defects in Niemann-Pick type C and evaluate proteostatic therapies.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into the endogenous NPC1 locus enables real-time tracking of NPC1 localization and transport dynamics in live cells.
Overexpression
Overexpression of ABCG1 or LYCHOS using CRISPR activation or lentiviral vectors can enhance sterol efflux or cholesterol sensing, respectively, to study gain-of-function effects [4,7].
How EDITGENE Supports sterol transmembrane transport Research
Researchers studying sterol transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in sterol movement, how mutations affect protein function, and whether therapeutic intervention can restore normal transport. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for sterol transmembrane transport research.
Frequently Asked Questions About sterol transmembrane transport
What is sterol transmembrane transport?
Sterol transmembrane transport (GO:0035382) is the process of moving sterol molecules across cellular membranes, often mediated by specific transport proteins.
What genes are involved in sterol transmembrane transport?
Key genes include NPC1, NPC2, ABCG1, LYCHOS, and Lamp1, which mediate or regulate sterol movement [1,2,4,7].
How is sterol transmembrane transport regulated?
It is regulated by mTORC1 signaling via lysosomal cholesterol sensing and by nuclear receptors controlling transporter expression [1,7].
What diseases are associated with defects in sterol transmembrane transport?
Niemann-Pick type C disease, hepatocellular carcinoma, and atherosclerosis are linked to impaired sterol transport [1,6,7,8].
What methods are used to study sterol transmembrane transport?
Common methods include filipin staining, BODIPY-cholesterol imaging, CRISPR screens, lipidomics, and transport assays [1,5,6].
Can CRISPR be used to study sterol transmembrane transport?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to dissect gene function in sterol transport [6,8].
What is the role of NPC1 in sterol transport?
NPC1 mediates the export of cholesterol from lysosomes, and its mutations cause Niemann-Pick type C disease [1,8].
How does ABCG1 contribute to sterol transport?
ABCG1 facilitates the efflux of cholesterol and other sterols from cells to HDL, protecting against atherosclerosis.
What is LYCHOS and how does it relate to sterol transport?
LYCHOS is a hybrid PIN transporter-GPCR that senses cholesterol and regulates mTORC1 signaling.
What model systems are available for studying sterol transmembrane transport?
Models include knockout cell lines, mutant induced neurons, humanized mice, and Drosophila mutants [2,8].
Conclusion
Sterol transmembrane transport (GO:0035382) is a fundamental biological process that ensures proper distribution of cholesterol and other sterols within cells. Its dysregulation underlies severe diseases such as Niemann-Pick type C, cancer, and atherosclerosis [1,6,7,8]. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular players and regulatory mechanisms, offering promising avenues for therapeutic intervention [4,5,8]. EDITGENE supports these efforts with tailored CRISPR services to accelerate discovery in sterol transport research.
References
- 1. Castellano BM et al.. 2017. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.. Science 355(6331):1306-1311 PMID: 28336668
- 2. Chaudhry N et al.. 2022. Lamp1 mediates lipid transport, but is dispensable for autophagy in Drosophila.. Autophagy 18(10):2443-2458 PMID: 35266854
- 3. Kim J et al.. 2022. Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation.. ACS Nano 16(9):14792-14806 PMID: 36038136
- 4. Bayly-Jones C et al.. 2024. LYCHOS is a human hybrid of a plant-like PIN transporter and a GPCR.. Nature 634(8036):1238-1244 PMID: 39358511
- 5. Maxfield FR et al.. 2006. Intracellular sterol transport and distribution.. Curr Opin Cell Biol 18(4):379-85 PMID: 16806879
- 6. Li S et al.. 2025. NPC1 controls TGFBR1 stability in a cholesterol transport-independent manner and promotes hepatocellular carcinoma progression.. Nat Commun 16(1):439 PMID: 39762312
- 7. Tarling EJ. 2013. Expanding roles of ABCG1 and sterol transport.. Curr Opin Lipidol 24(2):138-46 PMID: 23340182
- 8. Azaria RD et al.. 2024. Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapies.. JCI Insight 9(20) PMID: 39207850
